Detalles de la búsqueda
1.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med;
384(16): 1529-1541, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882206
2.
Typhoid vaccine does not impact feelings of social connection or social behavior in a randomized crossover trial among middle-aged female breast cancer survivors.
Brain Behav Immun;
107: 124-131, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208853
3.
Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
Nutr Cancer;
75(1): 265-275, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35968582
4.
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial.
Ann Behav Med;
57(10): 888-898, 2023 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335884
5.
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.
Support Care Cancer;
31(12): 717, 2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991653
6.
Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory.
Int J Behav Med;
30(4): 463-472, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35831698
7.
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health study.
Breast Cancer Res;
24(1): 78, 2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36376974
8.
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
Breast Cancer Res Treat;
195(2): 127-139, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545724
9.
Breast cancer survivors' typhoid vaccine responses: Chemotherapy, obesity, and fitness make a difference.
Brain Behav Immun;
103: 1-9, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35378230
10.
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series.
Breast Cancer Res Treat;
186(2): 569-575, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507482
11.
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer.
Breast Cancer Res Treat;
190(2): 183-188, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498153
12.
Genomic features of rapid versus late relapse in triple negative breast cancer.
BMC Cancer;
21(1): 568, 2021 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006255
13.
Worry and rumination in breast cancer patients: perseveration worsens self-rated health.
J Behav Med;
44(2): 253-259, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33135103
14.
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.
Invest New Drugs;
38(5): 1400-1410, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31953695
15.
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.
Invest New Drugs;
38(5): 1605-1611, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31938949
16.
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
BMC Cancer;
20(1): 445, 2020 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429929
17.
Metastatic breast cancer patient perceptions of somatic tumor genomic testing.
BMC Cancer;
20(1): 389, 2020 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375690
18.
The impact of granulocyte colony-stimulating factor use in patients with metastatic breast cancer treated with palliative chemotherapy: a single-institution retrospective review.
Support Care Cancer;
28(11): 5537-5545, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185556
19.
Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Support Care Cancer;
28(8): 3669-3677, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31811486
20.
Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience.
J Oncol Pharm Pract;
26(3): 572-579, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31256745